How long should I wait before investigating a neck lump in an adult?

Any neck lump in an adult that persists beyond three weeks without a clear infective or inflammatory explanation warrants investigation. Reactive nodes from a respiratory infection often resolve within two to four weeks. However, if the lump is hard, fixed, painless, or accompanied by weight loss, voice change, dysphagia, or night sweats, do not wait — investigate immediately. In adults over 40 with any of these features, refer urgently through the Cancer Council two-week pathway rather than observing. A brief one-week antibiotic trial is reasonable only if the lump is clearly inflammatory, but never as a substitute for investigation and follow-up.

What is HPV-related oropharyngeal cancer and why is it rising in Australia?

HPV-related oropharyngeal squamous cell carcinoma is the fastest-growing head and neck cancer in Australia, now accounting for approximately 70% of all oropharyngeal SCC. It typically affects middle-aged males in their 40s to 60s and presents as a painless cystic neck node — sometimes mistaken for a branchial cyst. Risk comes from oral HPV exposure, not smoking or alcohol. The Gardasil-9 vaccine is funded on the National Immunisation Program for adolescents and catch-up to age 26, and is expected to reduce the incidence over time. All persistent cystic neck nodes in adults should be assessed by ENT, not assumed to be congenital branchial cysts.

What are the red flags in a neck lump that need same-day or urgent action?

Refer urgently to ENT via the Cancer Council two-week pathway if there is a persistent neck lump over three weeks in an adult, a hard or fixed node, supraclavicular lymphadenopathy (Virchow node concern for gastric or thoracic malignancy), or B symptoms — fever, night sweats, and weight loss suggesting lymphoma. Send to emergency department if there is acute airway compromise, a rapidly enlarging tense abscess with fever and trismus (peritonsillar or retropharyngeal abscess), or sepsis. Refer urgently to haematology if lymphoma features are present — rubbery painless lymphadenopathy with B symptoms.

What causes a parotid or salivary gland swelling?

Salivary gland swelling has several important causes to distinguish. Bacterial parotitis presents in dehydrated elderly patients as acute tender unilateral parotid swelling with expressed pus from the duct — treat with antibiotics and hydration. Sialolithiasis (salivary duct stone) is most common in the submandibular gland — presents as pain with eating that resolves between meals, with a palpable stone on bimanual examination; managed conservatively then by sialendoscopy. Pleomorphic adenoma is the most common benign parotid tumour — slow-growing, painless, firm — and requires surgical excision. Any salivary mass with facial nerve palsy or fixation is malignant until proven otherwise and requires urgent ENT referral.

What investigations are needed for a neck lump?

Start with a targeted history covering smoking, alcohol, HPV risk, weight loss, dysphagia, and voice change — then a full ENT and mucosal examination including the oral cavity, oropharynx, cranial nerves, and skin. Bloods should include FBC, ESR, CRP, LDH, TFTs if midline or thyroid involvement is suspected, and HIV serology. Ultrasound is first-line imaging — non-invasive, MBS-rebatable, characterises the lesion and guides FNA. FNA cytology is the primary diagnostic procedure in adult persistent neck lumps. CT neck with contrast and staging CT are for confirmed or strongly suspected malignancy, guided by ENT in the context of an MDT.

Neck mass

Neck lump and salivary disorders: the Australian general practice approach

By Dr HB Lo, FACRRM Reviewed 24 September 2026 8 min read

A neck lump in a child is almost always reactive lymphadenopathy from a respiratory tract infection. In an adult over 40, a persistent neck lump lasting more than three weeks is considered malignant until proven otherwise — particularly given Australia's rising incidence of HPV-related oropharyngeal cancer.

Workup: history, ENT and mucosal examination, FBC and LDH, and ultrasound. FNA cytology characterises the lesion. Any adult with a persistent neck lump over three weeks, a hard or fixed node, supraclavicular lymphadenopathy, or B symptoms should be referred through the Cancer Council two-week urgent pathway to ENT.

A palpable neck lump is one of the more consequential presentations in Australian general practice because the differential spans the entirely benign — a reactive lymph node from last week’s cold — to the immediately life-threatening — an abscess compressing the airway, or a head and neck cancer that has been present for months. The decision framework rests on two key variables: age and duration. In children and young adults, the vast majority of neck lumps are reactive and self-resolving. In adults over 40, a neck lump persisting beyond three weeks is considered malignant until proven otherwise — this is the position of the Cancer Council Australia Optimal Care Pathway for Head and Neck Cancers, and it reflects a real and rising burden. Australia sees approximately 5,500 new head and neck cancers annually per AIHW cancer statistics, and HPV-related oropharyngeal squamous cell carcinoma is now the fastest-growing subtype.

A. Core clinical — the AU general-practice framework

Anatomy of the differential

Neck lump differential diagnosis is shaped by anatomical location, age, tempo, and associated features.

Midline neck lumps: thyroglossal duct cyst (moves with tongue protrusion and swallowing), dermoid, thyroid nodule or goitre, plunging ranula.

Lateral anterior triangle (levels I–IV): reactive or suppurative lymphadenopathy, metastatic squamous cell carcinoma, branchial cyst (differentiate from cystic HPV-related oropharyngeal cancer node in adults), carotid body tumour (paraganglioma — pulsatile, mobile horizontally not vertically, bruit), submandibular salivary gland lesion.

Lateral posterior triangle (level V): lymphadenopathy (reactive, lymphoma, metastatic), lipoma, soft-tissue sarcoma.

Supraclavicular: high-priority zone — left supraclavicular (Virchow node) suggests gastric or abdominal malignancy; right suggests thoracic primary; bilateral suggests lymphoma or widespread malignancy.

Parotid region: salivary tumour, parotid lymph node metastasis, Warthin tumour.

History

The history for a neck lump targets oncological risk factors and temporal pattern:

When first noticed and size change — rapid growth suggests infection or lymphoma; slow painless growth over months suggests malignancy or benign tumour.
Constitutional symptoms — weight loss, night sweats, fever (B symptoms: lymphoma). Fatigue, anorexia.
Local symptoms — voice change or hoarseness (laryngeal cancer, recurrent laryngeal nerve involvement), dysphagia (hypopharyngeal or oesophageal cancer), odynophagia, persistent unilateral ear pain without ear cause (referred otalgia from oropharyngeal cancer), nasal obstruction and epistaxis (nasopharyngeal carcinoma).
Risk factors: smoking (laryngeal, hypopharyngeal, oral SCC — synergistic with alcohol), alcohol, HPV exposure history, EBV exposure (Asian or Pacific Islander origin increases nasopharyngeal carcinoma risk), prior head and neck radiation, family history of MEN or medullary thyroid cancer, HIV status.
Salivary symptoms: pain with eating suggesting sialolithiasis, dry mouth (Sjögren syndrome), fever (acute sialadenitis).
Medications: phenytoin causes gum hyperplasia and lymphadenopathy; allopurinol drug rash with lymphadenopathy; DMARD-treated patients have elevated lymphoma risk.

Examination

Full ENT and head-and-neck examination is required:

Lump assessment: anatomical level, size (measured in centimetres), shape, texture (soft, firm, hard, rubbery, fluctuant), tenderness, mobility (mobile = more likely benign; hard and fixed = concerning for malignancy), overlying skin, pulsatility.
Mouth and oropharynx: tonsillar asymmetry (unilateral persistent tonsillar enlargement is HPV-related oropharyngeal SCC until proven otherwise), ulcers, leukoplakia, floor of mouth, tongue.
Cranial nerve assessment: VII (facial nerve — palsy with parotid mass is malignant until proven otherwise), V, IX, X, XII.
Thyroid: separate palpation, moves with swallowing.
Skin: scalp, face, ears — melanoma metastasis to neck nodes is a common and missed diagnosis; full skin examination.
Spleen and axillary/inguinal nodes — splenomegaly or generalised lymphadenopathy suggests lymphoma or EBV.
Salivary glands: bimanual palpation of submandibular gland, expressed pus or stone from duct.

Investigations

Bloods: FBC with differential, ESR, CRP, LDH (lymphoma marker), TFTs if thyroid or midline involvement, calcium (hypercalcaemia of malignancy, parathyroid disease), HIV serology, EBV serology (MBS item 69345), quantiferon-TB if exposure history.

Ultrasound is first-line imaging (MBS item 55028 for neck soft tissue; MBS item 55054 for thyroid) — characterises echogenicity, internal architecture, vascularity, and cystic versus solid nature; identifies thyroid, salivary, lymphatic, and vascular masses; guides FNA. Non-invasive, widely available, and MBS-rebatable.

FNA cytology (MBS item 73846) — the primary diagnostic procedure in adult persistent neck lumps; performed by ENT or radiology under ultrasound guidance. Note: excisional biopsy of a neck node in an adult without prior specialist review is contraindicated — it may seed squamous cell carcinoma and disrupts lymph node architecture needed for lymphoma staging.

B. Evidence — the two-week pathway and HPV

The Cancer Council two-week urgent referral pathway for persistent neck lumps in adults is the standard of care in Australia, supported by the Cancer Council Optimal Care Pathway for Head and Neck Cancers. It mirrors the NICE NG12 two-week-wait approach from the UK, backed by evidence that earlier specialist review reduces diagnostic delay and improves survival outcomes for head and neck SCC.

HPV-related oropharyngeal SCC now accounts for approximately 70% of oropharyngeal squamous cell carcinoma in Australia, with incidence rising rapidly in middle-aged males. These tumours frequently present as a painless cystic lateral neck node — a pattern that has historically been attributed to benign branchial cysts. In any adult with a cystic lateral neck node, especially with HPV risk factors, ENT assessment with FNA and p16 immunohistochemistry is indicated before labelling the lesion congenital.

HPV-related oropharyngeal SCC has a significantly better prognosis than HPV-negative disease, but still requires specialist management. Gardasil-9 vaccination, funded on the National Immunisation Program for adolescents and catch-up to age 26 per the Australian Immunisation Handbook, is expected to reduce incidence over the coming decades as vaccinated cohorts enter peak cancer risk age.

C. Salivary gland disorders

Acute bacterial parotitis typically affects dehydrated older adults — fever, unilateral tender parotid swelling, and pus expressed from Stensen duct. Treat with antibiotics per eTG: Antibiotic: oral dicloxacillin or flucloxacillin 500 mg four times daily, with clindamycin for penicillin allergy; IV route and drainage for severe disease.

Sialolithiasis (salivary duct stones) is most common in the submandibular gland (~80%), where the duct runs uphill and the secretion is more alkaline and viscous. Presentation is predictable: pain with meals that eases between. Management begins with conservative measures — hydration, warm compresses, massage, sialogogues (lemon or sour candy). ENT referral for sialendoscopy and stone removal or surgical excision for impacted stones.

Pleomorphic adenoma is the most common benign salivary tumour, predominantly in the parotid, presenting as a slow-growing painless firm mass in middle-aged adults. The capsule is incomplete — enucleation risks local recurrence; superficial parotidectomy with facial nerve preservation is the appropriate operation. Refer to ENT for FNA and surgery.

Sjögren syndrome causes bilateral salivary and lacrimal gland enlargement with sicca symptoms (dry mouth and eyes), positive ANA, anti-SSA, and anti-SSB antibodies. Management is symptomatic — artificial saliva, pilocarpine — with rheumatology or immunology involvement for systemic manifestations.

D. Australian operations

MBS pathways: GP consultations at level B (item 23), C (item 36), or D (item 44). Neck ultrasound (MBS 55028), thyroid USS (MBS 55054), CT neck with contrast (MBS 56401), FNA cytology (MBS 73846), ENT specialist consultations (MBS items 104 and 105), GPCCMP for post-cancer survivors (MBS items 965 and 967), and mental health care plan for cancer-related distress (MBS items 2715 and 2717).

PBS antibiotic access: flucloxacillin and dicloxacillin for bacterial sialadenitis are General Schedule. Pilocarpine for Sjögren is Authority Required.

Cancer Council support line: 13 11 20 is the patient-facing Cancer Council support line, available for all patients with a new cancer diagnosis or investigation in progress. Beyond Five provides specific support for head and neck cancer patients.

ATSI and Pacific populations: Aboriginal and Torres Strait Islander patients have higher rates of head and neck SCC, lower rates of timely diagnosis, and lower five-year survival. The Cancer Council Optimal Care Pathway for Aboriginal and Torres Strait Islander people emphasises culturally safe care, smoking cessation, alcohol reduction, and community-controlled health organisation partnerships. Pacific Islander populations — particularly of Maori, Samoan, Tongan, and Fijian background — have elevated nasopharyngeal carcinoma risk from EBV.

E. Special populations

Children: paediatric neck lumps are benign in approximately 95% of cases. Reactive lymphadenopathy from URTI is the predominant cause. Congenital lesions — thyroglossal duct cyst, branchial cyst, dermoid, cystic hygroma — present in childhood and infancy. Paediatric red flags requiring referral include supraclavicular location, hard or fixed nodes, B symptoms, node over 2 cm persisting beyond four weeks, or age under one year with any persistent lump.

Immunosuppressed patients: HIV-positive patients are at elevated risk of lymphoma, Kaposi sarcoma, and atypical infection. Neck lumps in HIV-positive patients require HIV viral load check, CD4 count, and immunology or haematology review alongside ENT assessment.

Post-treatment head and neck cancer survivors: xerostomia, dysphagia, lymphoedema of the neck, and fatigue are common late effects of radiotherapy. GPCCMP (MBS items 965/967) allows GP-coordinated allied-health referral to speech pathology, dietitian, dentist, lymphoedema therapist, and psychologist as part of a structured management plan.

When to escalate

Refer to ENT urgently via the Cancer Council two-week pathway when:

A neck lump in an adult persists for more than three weeks without a clear benign explanation.
A node is hard, fixed, or supraclavicular.
B symptoms are present — weight loss, night sweats, fever.
There is voice change, dysphagia, or persistent ear pain without ear cause.
Any salivary gland mass is identified — even painless, as approximately 20% of parotid masses are malignant.
Facial nerve palsy accompanies a parotid mass.

Refer to haematology urgently when lymphoma features are present — rubbery painless cervical, axillary, or inguinal lymphadenopathy with B symptoms, splenomegaly, or elevated LDH.

Send to emergency department immediately when there is acute airway compromise from a deep neck infection, rapidly expanding abscess with trismus (peritonsillar or retropharyngeal), or sepsis.

What this article is and is not

This is general health information drawn from current Australian guidelines — eTG, RACGP, Cancer Council Australia Optimal Care Pathway, Cancer Australia, and ASOHNS. It is not personal medical advice and does not create a doctor–patient relationship. Decisions about investigation and specialist referral are made in consultation with your own GP and clinical team based on your individual circumstances.

For Australian consumer resources: HealthDirect — lump on neck · Better Health Channel · Cancer Council 13 11 20 · Beyond Five — head and neck cancer.

For urgent symptoms — new airway difficulty, rapidly expanding neck swelling, fever with neck stiffness: call 000 or go to your nearest emergency department immediately.

Sources cited

Frequently asked questions

How long should I wait before investigating a neck lump in an adult?

Any neck lump in an adult that persists beyond three weeks without a clear infective or inflammatory explanation warrants investigation. Reactive nodes from a respiratory infection often resolve within two to four weeks. However, if the lump is hard, fixed, painless, or accompanied by weight loss, voice change, dysphagia, or night sweats, do not wait — investigate immediately. In adults over 40 with any of these features, refer urgently through the Cancer Council two-week pathway rather than observing. A brief one-week antibiotic trial is reasonable only if the lump is clearly inflammatory, but never as a substitute for investigation and follow-up.
What is HPV-related oropharyngeal cancer and why is it rising in Australia?

HPV-related oropharyngeal squamous cell carcinoma is the fastest-growing head and neck cancer in Australia, now accounting for approximately 70% of all oropharyngeal SCC. It typically affects middle-aged males in their 40s to 60s and presents as a painless cystic neck node — sometimes mistaken for a branchial cyst. Risk comes from oral HPV exposure, not smoking or alcohol. The Gardasil-9 vaccine is funded on the National Immunisation Program for adolescents and catch-up to age 26, and is expected to reduce the incidence over time. All persistent cystic neck nodes in adults should be assessed by ENT, not assumed to be congenital branchial cysts.
What are the red flags in a neck lump that need same-day or urgent action?

Refer urgently to ENT via the Cancer Council two-week pathway if there is a persistent neck lump over three weeks in an adult, a hard or fixed node, supraclavicular lymphadenopathy (Virchow node concern for gastric or thoracic malignancy), or B symptoms — fever, night sweats, and weight loss suggesting lymphoma. Send to emergency department if there is acute airway compromise, a rapidly enlarging tense abscess with fever and trismus (peritonsillar or retropharyngeal abscess), or sepsis. Refer urgently to haematology if lymphoma features are present — rubbery painless lymphadenopathy with B symptoms.
What causes a parotid or salivary gland swelling?

Salivary gland swelling has several important causes to distinguish. Bacterial parotitis presents in dehydrated elderly patients as acute tender unilateral parotid swelling with expressed pus from the duct — treat with antibiotics and hydration. Sialolithiasis (salivary duct stone) is most common in the submandibular gland — presents as pain with eating that resolves between meals, with a palpable stone on bimanual examination; managed conservatively then by sialendoscopy. Pleomorphic adenoma is the most common benign parotid tumour — slow-growing, painless, firm — and requires surgical excision. Any salivary mass with facial nerve palsy or fixation is malignant until proven otherwise and requires urgent ENT referral.
What investigations are needed for a neck lump?

Start with a targeted history covering smoking, alcohol, HPV risk, weight loss, dysphagia, and voice change — then a full ENT and mucosal examination including the oral cavity, oropharynx, cranial nerves, and skin. Bloods should include FBC, ESR, CRP, LDH, TFTs if midline or thyroid involvement is suspected, and HIV serology. Ultrasound is first-line imaging — non-invasive, MBS-rebatable, characterises the lesion and guides FNA. FNA cytology is the primary diagnostic procedure in adult persistent neck lumps. CT neck with contrast and staging CT are for confirmed or strongly suspected malignancy, guided by ENT in the context of an MDT.

Source quality

Sources grouped by evidence tier. AU primary tier first; international where AU is silent or lagging; named-author reconstruction where guidelines have not yet caught up. How tiers work.